| PharmaVOICE is the executive forum that allows
business leaders to engage in a candid dialogue on the myriad challenges
and trends impacting the life-sciences industry. PharmaVOICE reaches
more than 17,000 U.S.-based executives who influence business strategies
and affect change. Published monthly, PharmaVOICE provides readers
with insightful and thought-provoking commentary in a multiple-perspective
format through its forums, topics, and articles that cover a range of issues
from molecule through market.
Editorial Scope
PharmaVOICE, published 10 times a year, is expressly
written and designed to deliver the views, opinions, and insights of executives
who are shaping the direction of the dynamic life-sciences industry to
more than 17,000 readers.
PharmaVOICE provides multiple perspectives on the
business challenges, trends, and topics by engaging compelling personalities
from diverse industry sectors in a thoughtprovoking dialog to facilitate
and improve business-to-business relationships. PharmaVOICE’s unique
multiple-perspective and in-depth original forums, feature articles, topics,
and departments are audience-driven. PharmaVOICE provides executives
with useful peer-to-peer insights on a broad range of business practices
and topics, including, but not limited to the following life-science sectors:
• Advertising • Analysts
• Associations • Big Pharma • Biotech • Communications
• Consultants • Contract Research •
Contract Sales • Device/Diagnostic • Drug Delivery
• Drug Discovery • Emerging Pharma • Government • Healthcare
Professionals • Information Technology • Legal
• Marketing • Medical Education • Public Relations
• Regulatory • Research & Development • Service Support
• Specialty Pharma • Traditional and Nontraditional Media •
Venture Capital
|
